Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Gandrup
Clinical trial register · Denmark

Clinical Trials in Gandrup, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2460 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:17 UTC
2460
Studies in scope
all four open statuses
1394
Recruiting now
open to new participants
444
Lead sponsors
across recruiting studies
Top sites
Copenhagen 980 Aarhus 584 Odense 443 Aalborg 377 Herlev 307
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca5 Eli Lilly and Company4 Amgen2 Novartis Pharmaceuticals2 Merck Sharp & Dohme LLC2 Arctic Therapeutics1 Bioventus LLC1 Novo Nordisk A/S1 AriBio Co., Ltd.1 Enlivex Therapeutics Ltd.1 KeyBioscience AG1
Site location
Copenhagen980 Aarhus584 Odense443 Aalborg377 Herlev307 Aarhus N205 Vejle180 Hvidovre162 Roskilde141 Herning120 Odense C111 Esbjerg108 Hillerød102 Køge78 Hellerup77 Glostrup Municipality72 København Ø59 Frederiksberg50 Næstved49 Viborg45 Gistrup43 Randers36 Horsens36 Holbæk36 Gentofte Municipality34 Show all 126
All 126 locations
Target enrolment
to

Trials with a site in Gandrup

21 of 2460 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
AstraZeneca
Phase 3
500
Aarhus N, Gandrup, Herlev, Holbæk, Hvidovre, Middelfart, Odense, Vejle
2026-08-24
Recruiting
AstraZeneca
Phase 3
600
Aarhus, Copenhagen, Gandrup, Herlev, Herning, Svendborg, Vejle, Viborg
2026-08-12
Recruiting
AstraZeneca
Phase 3
2,000
Aarhus N, Esbjerg, Gandrup, Herlev, Hillerød, Hvidovre, Odense
2026-07-06
Recruiting
AstraZeneca
Phase 3
800
Gandrup, Herlev, Hillerød, Hvidovre
2026-07-06
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
Viborg, Gandrup, Esbjerg, Svendborg
2026-06-30
Recruiting
Enlivex Therapeutics Ltd.
Phase 2
182
Gandrup, Herlev, Vejle
2026-05-01
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Vejle, Gandrup, Gistrup, Hellerup, Hillerød, Hvidovre
2026-02-24
Recruiting
Eli Lilly and Company
Phase 3
900
Gandrup, Herlev, Vejle
2026-02-09
Active, closed
Arctic Therapeutics
Phase 2
33
Gandrup, Herlev, Vejle
2025-10-14
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Gandrup, Herlev, Vejle
2025-09-02
Active, closed
Amgen
Phase 3
12,800
Aalborg, Aarhus N, Esbjerg, Gandrup, Herlev, Herning, Holbæk, Hvidovre
2025-07-25
Recruiting
AstraZeneca
Phase 3
15,100
Aarhus N, Copenhagen, Esbjerg, Frederiksberg, Gandrup, Gistrup, Herlev, Herning
2025-06-04
Active, closed
Amgen
Phase 3
3,853
Gandrup, Hellerup, Herlev, Herning, Hvidovre
2025-03-12
Recruiting
Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
NCT06833749Osteoarthritis in the Knee, Obesity
KeyBioscience AG
Phase 2
600
Gandrup, Herlev, Vejle
2025-01-28
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Esbjerg, Gandrup, Vejle
2024-06-28
Active, closed
Eli Lilly and Company
Phase 3
10,000
Aabenraa, Aarhus, Gandrup, Herlev, Vejle
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aabenraa, Aarhus, Copenhagen, Esbjerg, Gandrup, Herlev, Holbæk, Vejle
2024-03-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Copenhagen, Herlev, Aarhus, Herning, Gandrup, Hjørring, Roskilde, Slagelse
2023-10-09
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Aarhus N, Copenhagen S, Esbjerg, Gandrup, Herlev, Herning, Kobenhavn N V, Roskilde
2023-03-09
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Gandrup, Herlev, Vejle
2022-12-23
Active, closed
Bioventus LLC
Phase 2
210
Gandrup, Herlev, Vejle
2021-09-30
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-denmark/city/gandrup

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,460 studies in total at the last sync on 12 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Gandrup.

How many clinical trials are recruiting in Gandrup?

11 of the 21 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gandrup), 21 studies
PhaseStudiesRecruitingShare
Phase 316876.2%
Phase 25323.8%

Most active sponsors

Lead sponsors with the most studies (Gandrup)
Lead sponsorStudiesRecruiting
AstraZeneca55
Eli Lilly and Company42
Amgen20
Merck Sharp & Dohme LLC21
Novartis Pharmaceuticals20
Arctic Therapeutics10
AriBio Co., Ltd.10
Bioventus LLC10
Enlivex Therapeutics Ltd.11
KeyBioscience AG11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.